Marbeuf-Gueye C - Search Results

1

Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts.

Reungpatthanaphong P, Marbeuf-Gueye C, Le Moyec L, Salerno M, Garnier-Suillerot A. Reungpatthanaphong P, et al. Among authors: marbeuf gueye c. J Bioenerg Biomembr. 2004 Dec;36(6):533-43. doi: 10.1007/s10863-004-9000-8. J Bioenerg Biomembr. 2004. PMID: 15692732

2

New insights into the P-glycoprotein-mediated effluxes of rhodamines.

Loetchutinat C, Saengkhae C, Marbeuf-Gueye C, Garnier-Suillerot A. Loetchutinat C, et al. Among authors: marbeuf gueye c. Eur J Biochem. 2003 Feb;270(3):476-85. doi: 10.1046/j.1432-1033.2003.03403.x. Eur J Biochem. 2003. PMID: 12542697 Free article.

3

Impact of exogenous lysolipids on sensitive and multidrug resistant K562 cells: 1H NMR studies.

Traïkia M, Marbeuf-Gueye C, Hantz E, Le Moyec L. Traïkia M, et al. Among authors: marbeuf gueye c. Chem Biol Interact. 2005 Jan 15;151(2):83-94. doi: 10.1016/j.cbi.2004.12.005. Chem Biol Interact. 2005. PMID: 15698580

4

Perturbation of membrane microdomains in GLC4 multidrug-resistant lung cancer cells--modification of ABCC1 (MRP1) localization and functionality.

Marbeuf-Gueye C, Stierle V, Sudwan P, Salerno M, Garnier-Suillerot A. Marbeuf-Gueye C, et al. FEBS J. 2007 Mar;274(6):1470-80. doi: 10.1111/j.1742-4658.2007.05688.x. FEBS J. 2007. PMID: 17489102 Free article.

5

Caveolin-1 and doxorubicin-induced P-glycoprotein modulate plasma cholesterol membrane accessibility in erythrolymphoblastic cell line.

Zhu M, LE Moyec L, Starzec A, Stierle V, Marbeuf-Gueye C. Zhu M, et al. Among authors: marbeuf gueye c. Anticancer Res. 2010 Sep;30(9):3451-8. Anticancer Res. 2010. PMID: 20944122

6

Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.

Marbeuf-Gueye C, Ettori D, Priebe W, Kozlowski H, Garnier-Suillerot A. Marbeuf-Gueye C, et al. Biochim Biophys Acta. 1999 Jul 8;1450(3):374-84. doi: 10.1016/s0167-4889(99)00060-9. Biochim Biophys Acta. 1999. PMID: 10395948 Free article.

7

Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.

Marbeuf-Gueye C, Salerno M, Quidu P, Garnier-Suillerot A. Marbeuf-Gueye C, et al. Eur J Pharmacol. 2000 Mar 17;391(3):207-16. doi: 10.1016/s0014-2999(00)00047-9. Eur J Pharmacol. 2000. PMID: 10729360

8

Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes.

Marbeuf-Gueye C, Priebe W, Garnier-Suillerot A. Marbeuf-Gueye C, et al. Biochem Pharmacol. 2000 Nov 15;60(10):1485-9. doi: 10.1016/s0006-2952(00)00453-6. Biochem Pharmacol. 2000. PMID: 11020450

9

Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.

Garnier-Suillerot A, Marbeuf-Gueye C, Salerno M, Loetchutinat C, Fokt I, Krawczyk M, Kowalczyk T, Priebe W. Garnier-Suillerot A, et al. Curr Med Chem. 2001 Jan;8(1):51-64. doi: 10.2174/0929867013373967. Curr Med Chem. 2001. PMID: 11172692 Review.

10

Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.

Marbeuf-Gueye C, Broxterman HJ, Dubru F, Priebe W, Garnier-Suillerot A. Marbeuf-Gueye C, et al. Mol Pharmacol. 1998 Jan;53(1):141-7. doi: 10.1124/mol.53.1.141. Mol Pharmacol. 1998. PMID: 9443942

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters